Brain angiogenesis after stroke

Biochemical Basis and Therapeutic Implications of Angiogenesis

Volumn , Issue , 2013, Pages 239-260

  Hayakawa, Kazuhide ^a   Seo, Ji Hae ^a   Miyamoto, Nobukazu ^a   Pham, Loc Duyen D ^a   Navaratna, Deepti ^a   Lo, Eng H ^a   Arai, Ken ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Biphasic response; Brain remodeling; Cerebral endothelial cell; Neurovascular niche; Neurovascular unit; Oligovascular niche; Stroke

Indexed keywords

EID: 84899803591     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5857-9_14     Document Type: Chapter

References (164)

1. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP (2008) National us estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39:924-928
2. Shuaib A, Lees KR, Lyden P et al (2007) NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357:562-571
3. Chopp M, Zhang ZG, Jiang Q (2007) Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38:827-831
4. Chopp M, Li Y, Zhang J (2008) Plasticity and remodeling of brain. J Neurol Sci 265:97-101
5. Krupinski J, Kaluza J, Kumar P et al (1994) Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25:1794-1798
6. Chen HH, Chien CH, Liu HM (1994) Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 25:1651-1657
7. Marti HJ, Bernaudin M, Bellail A et al (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965-976
8. Hayashi T, Noshita N, Sugawara T, Chan PH (2003) Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 23:166-180
9. Krupinski J, Kaluza J, Kumar P et al (1993) Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol 44:203-209
10. Szpak GM, Lechowicz W, Lewandowska E et al (1999) Border zone neovascularization in cerebral ischemic infarct. Folia Neuropathol 37:264-268
11. Allen CM (1984) Predicting outcome after acute stroke: role of computerised tomography. Lancet 2:464-465
12. Granger CV, Hamilton BB, Fiedler RC (1992) Discharge outcome after stroke rehabilitation. Stroke 23:978-982
13. Schmidt R, Schmidt H, Fazekas F (2000) Vascular risk factors in dementia. J Neurol 247:81-87
14. Manoonkitiwongsa PS, Jackson-Friedman C, McMillan PJ et al (2001) Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J Cereb Blood Flow Metab 21:1223-1231
15. Yu SW, Friedman B, Cheng Q, Lyden PD (2007) Stroke-evoked angiogenesis results in a transient population of microvessels. J Cereb Blood Flow Metab 27:755-763
16. Fagan SC, Hess DC, Hohnadel EJ et al (2004) Targets for vascular protection after acute ischemic stroke. Stroke 35:2220-2225
17. Hansen TM, Moss AJ, Brindle NP (2008) Vascular endothelial growth factor and angiopoi- etins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res 5:236-245
18. Abe K, Setoguchi Y, Hayashi T, Itoyama Y (1997) Dissociative expression of adenoviral- mediated E. coli LacZ gene between ischemic and reperfused rat brains. Neurosci Lett 226:53-56
19. Zhang ZG, Zhang L, Jiang Q et al (2000) VEGF enhances angiogenesis and promotes blood- brain barrier leakage in the ischemic brain. J Clin Invest 106:829-838
20. Issa R, Krupinski J, Bujny T et al (1999) Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest 79:417-425
21. Sun Y, Jin K, Xie L et al (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111:1843-1851
22. Wang Y, Kilic E, Kilic U et al (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128:52-63
23. Yano A, Shingo T, Takeuchi A et al (2005) Encapsulated vascular endothelial growth factor- secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103:104-114
24. Wada K, Sugimori H, Bhide PG et al (2003) Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats. Stroke 34:2722-2728
25. Speliotes EK, Caday CG, Do T et al (1996) Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res Mol Brain Res 39:31-42
26. Issa R, AlQteishat A, Mitsios N, Saka M, Krupiński J, Tarkowski E, Gaffney J, Slevin M, Kumar S, Kumar P (2005) Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8:53-62
27. Jiang N, Finklestein SP, Do T et al (1996) Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/ reperfusion in the rat. J Neurol Sci 139:173-179
28. Kawamata T, Dietrich WD, Schallert T et al (1997) Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A 94:8179-8184
29. Li Q, Stephenson D (2002) Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat. Exp Neurol 177:531-537
30. Kawamata T, Speliotes EK, Finklestein SP (1997) The role of polypeptide growth factors in recovery from stroke. Adv Neurol 73:377-382
31. Ren JM, Finklestein SP (2005) Growth factor treatment of stroke. Curr Drug Targets CNS Neurol Disord 4:121-125
32. Yamagishi S, Imaizumi T (2005) Pericyte biology and diseases. Int J Tissue React 27:125-135
33. Renner O, Tsimpas A, Kostin S et al (2003) Time- and cell type-specific induction of platelet- derived growth factor receptor-beta during cerebral ischemia. Brain Res Mol Brain Res 113:44-51
34. Krupinski J, Issa R, Bujny T et al (1997) A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 28:564-573
35. Vivien D, Ali C (2006) Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev 17:121-128
36. Krupinski J, Kumar P, Kumar S, Kaluza J (1996) Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857
37. Ata AK, Funa K, Olsson Y (1997) Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 93:326-333
38. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J (2000) Serial measurement of vascular endothelial growth factor and transforming growth factor-beta! in serum of patients with acute ischemic stroke. Stroke 31:1863-1870
39. Zhang ZG, Zhang L, Jiang Q, Chopp M (2002) Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90:284-288
40. Krupinski J, Vodovotz Y, Li C et al (1998) Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide 2:442-453
41. Prehn JH, Backhauss C, Krieglstein J (1993) Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 13:521-525
42. Prehn JH, Peruche B, Unsicker K, Krieglstein J (1993) Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J Neurochem 60:1665-1672
43. Le Cras TD, Spitzmiller RE, Albertine KH et al (2004) VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 287:L134-L142
44. van Bruggen N, Thibodeaux H, Palmer JT et al (1999) VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104:1613-1620
45. Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491-500
46. Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14:497-500
47. Navaratna D, Guo S, Arai K, Lo E (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 3:216-239
48. Anthony DC, Ferguson B, Matyzak MK et al (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23:406-415
49. Montaner J, Alvarez-Sabin J, Molina C et al (2001) Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32:1759-1766
50. Rosell A, Alvarez-Sabin J, Arenillas JF et al (2005) A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 36:1415-1420
51. Alvarez-Sabin J, Delgado P, Abüleira S et al (2004) Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35:1316-1322
52. Horstmann S, Kalb P, Koziol J et al (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34:2165-2170
53. Zhao BQ, Wang S, Kim HY et al (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441-445
54. Lee SR, Kim HY, Rogowska J et al (2006) Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci 26:3491-3495
55. Yang H, Wang H, Czura CJ, Tracey KJ (2005) The cytokine activity of HMGB1. J Leukoc Biol 78:1-8
56. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342
57. Qiu J, Nishimura M, Wang Y et al (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28:927-938
58. Kim JB, Sig Choi J, Yu YM et al (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26:6413-6421
59. Hayakawa K, Mishima K, Nozako M et al (2008) Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 39:951-958
60. Nakahara T, Tsuruta R, Kaneko T et al (2009) High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 11:362-368
61. Cohen MJ, Brohi K, Calfee CS et al (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 13:R174
62. Treutiger CJ, Mullins GE, Johansson AS et al (2003) High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 254:375-385
63. Schlueter C, Weber H, Meyer B et al (2005) Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 166:1259-1263
64. Huttunen HJ, Kuja-Panula J, Sorci G et al (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275:40096-40105
65. Huttunen HJ, Kuja-Panula J, Rauvala H (2002) Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 277:38635-38646
66. Passalacqua M, Patrone M, Picotti GB et al (1998) Stimulated astrocytes release high- mobility group 1 protein, an inducer of lan-5 neuroblastoma cell differentiation. Neuroscience 82:1021-1028
67. Kuan CY, Burke RE (2005) Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord 4:63-67
68. Waetzig V, Zhao Y, Herdegen T (2006) The bright side of JNKs-multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80:84-97
69. Uchida C, Gee E, Ispanovic E, Haas TL (2008) JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 32:769-776
70. Miura S, Matsuo Y, Saku K (2008) Jun N-terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and an MMP pathway. J Atheroscler Thromb 15:69-74
71. Yoshino Y, Aoyagi M, Tamaki M et al (2006) Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int J Oncol 29:981-987
72. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
73. Taguchi A, Matsuyama T, Moriwaki H et al (2004) Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109:2972-2975
74. Sobrino T, Hurtado O, Moro MA et al (2007) The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 38:2759-2764
75. Yip HK, Chang LT, Chang WN et al (2008) Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39:69-74
76. Chavakis E, Hain A, Vinci M et al (2007) High-mobility group box 1 activates integrin- dependent homing of endothelial progenitor cells. Circ Res 100:204-212
77. Rosell A, Arai K, Lok J et al (2009) Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab 29:933-943
78. Hayakawa K, Pham L-D, Katusic Z et al (2012) Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A 109:7505-7515
79. Rouhl RP, van Oostenbrugge RJ, Damoiseaux J et al (2008) Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 39:2158-2165
80. Ziegelhoeffer T, Fernandez B, Kostin S et al (2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238
81. O'Neill TJT, Wamhoff BR, Owens GK, Skalak TC (2005) Mobilization of bone marrow- derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97:1027-1035
82. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415
83. del Zoppo GJ (2006) Stroke and neurovascular protection. N Engl J Med 354:553-555
84. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360
85. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201
86. Lok J, Gupta P, Guo S et al (2007) Cell-cell signaling in the neurovascular unit. Neurochem Res 32:2032-2045
87. Besancon E, Guo S, Lok J, Tymianski M, Lo EH (2008) Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 29:268-275
88. Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439-447
89. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796-808
90. Lo EH (2010) Degeneration and repair in central nervous system disease. Nat Med 16:1205-1209
91. Lo EH, Moskowitz MA, Jacobs TP (2005) Exciting, radical, suicidal: how brain cells die after stroke. Stroke 36:189-192
92. Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369-1376
93. Zhao BQ, Tejima E, Lo EH (2007) Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 38:748-752
94. Asahi M, Asahi K, Jung JC et al (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681-1689
95. Gasche Y, Fujimura M, Morita-Fujimura Y et al (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 19:1020-1028
96. Heo JH, Lucero J, Abumiya T et al (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624-633
97. Kelly PJ, Morrow JD, Ning M et al (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39:100-104
98. Asahi M, Wang X, Mori T et al (2001) Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724-7732
99. Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and timps are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189-2195
100. Tagaya M, Haring HP, Stuiver I et al (2001) Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 21:835-846
101. Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin- catalyzed degradation of laminin. Cell 91:917-925
102. Dijkhuizen RM, Singhal AB, Mandeville JB et al (2003) Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci 23:510-517
103. Murphy TH, Corbett D (2009) Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 10:861-872
104. Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436:193
105. Snapyan M, Lemasson M, Brill MS et al (2009) Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. J Neurosci 29:4172-4188
106. Zacchigna S, Lambrechts D, Carmeliet P (2008) Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 9:169-181
107. Greenberg DA, Jin K (2005) From angiogenesis to neuropathology. Nature 438:954-959
108. Leventhal C, Rafii S, Rafii D et al (1999) Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci 13:450-464
109. Shen Q, Goderie SK, Jin L et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338-1340
110. Guo S, Kim WJ, Lok J et al (2008) Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105:7582-7587
111. Thored P, Wood J, Arvidsson A et al (2007) Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38:3032-3039
112. Ohab JJ, Fleming S, Blesch A, Carmichael ST (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26:13007-13016
113. Taguchi A, Soma T, Tanaka H et al (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338
114. Ding G, Jiang Q, Li L et al (2008) Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI. Stroke 39:1563-1568
115. Arai K, Lo EH (2009) Oligovascular signaling in white matter stroke. Biol Pharm Bull 32:1639-1644
116. Butt AM, Ibrahim M, Ruge FM, Berry M (1995) Biochemical subtypes of oligodendrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody Rip. Glia 14:185-197
117. Orthmann-Murphy JL, Abrams CK, Scherer SS (2008) Gap junctions couple astrocytes and oligodendrocytes. J Mol Neurosci 35:101-116
118. Corley SM, Ladiwala U, Besson A, Yong VW (2001) Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism. Glia 36:281-294
119. Arai K, Lo EH (2010) Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res 88:758-763
120. Nave KA, Trapp BD (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535-561
121. Rosenberg SS, Ng BK, Chan JR (2006) The quest for remyelination: a new role for neuro- trophins and their receptors. Brain Pathol 16:288-294
122. Chandler S, Coates R, Gearing A et al (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201:223-226
123. Arai K, Lo EH (2009) An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 29:4351-4355
124. Hayakawa K, Seo JH, Pham LD, Miyamoto N, Som AT, Guo S, Kim KW, Lo EH, Arai K (2012) Cerebral endothelial derived vascular endothelial growth factor promotes the migration but not the proliferation of oligodendrocyte precursor cells in vitro. Neurosci Lett 513:42-56
125. Hayakawa K, Pham LD, Som AT et al (2011) Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. J Neurosci 31:10666-10670
126. Pham LD, Hayakawa K, Seo JH et al (2012) Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 60:875-881
127. Weintraub MI (2006) Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke 37:1917-1922
128. Carmeliet P, Storkebaum E (2002) Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 13:39-53
129. Ferrara N, Gerber HP (2001) The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 106:148-156
130. Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437:497-504
131. Croll SD, Goodman JH, Scharfman HE (2004) Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Adv Exp Med Biol 548:57-68
132. Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225-237
133. Forstreuter F, Lucius R, Mentlein R (2002) Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132:93-98
134. Schoch HJ, Fischer S, Marti HH (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125:2549-2557
135. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW (1998) Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 27:163-173
136. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463
137. Mu D, Jiang X, Sheldon RA et al (2003) Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 14:524-534
138. Eliceiri BP, Paul R, Schwartzberg PL et al (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4:915-924
139. Jones CA, London NR, Chen H et al (2008) Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 14:448-453
140. Acevedo LM, Weis SM, Cheresh DA (2008) Robo4 counteracts VEGF signaling. Nat Med 14:372-373
141. Wallez Y, Huber P (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778:794-809
142. Vestweber D (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28:223-232
143. Liebner S, Cavallaro U, Dejana E (2006) The multiple languages of endothelial cell-to-cell communication. Arterioscler Thromb Vasc Biol 26:1431-1438
144. Tucker GC (2006) Integrins: molecular targets in cancer therapy. Curr Oncol Rep 8:96-103
145. Trikha M, Zhou Z, Timar J et al (2002) Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 62:2824-2833
146. Varner JA, Nakada MT, Jordan RE, Coller BS (1999) Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro). Angiogenesis 3:53-60
147. Carmeliet P, Collen D (2000) Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci 902:249-262; discussion 262-264
148. Grazia Lampugnani M, Zanetti A, Corada M et al (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase dep-1/cd148. J Cell Biol 161:793-804
149. Francavilla C, Loeffler S, Piccini D et al (2007) Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor. J Cell Sci 120:4388-4394
150. Skaper SD, Facci L, Williams G et al (2004) A dimeric version of the short N-cadherin binding motif HAVDI promotes neuronal cell survival by activating an N-cadherin/fibroblast growth factor receptor signalling cascade. Mol Cell Neurosci 26:17-23
151. Williams EJ, Furness J, Walsh FS, Doherty P (1994) Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13:583-594
152. Miljan EA, Sinden JD (2009) Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther 11:394-403
153. Richardson RM, Singh A, Sun D et al (2010) Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J Neurosurg 112:1125-1138
154. Roitbak T, Li L, Cunningham LA (2008) Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via hif-1 alpha-regulated VEGF signaling. J Cereb Blood Flow Metab 28:1530-1542
155. Locatelli F, Bersano A, Ballabio E et al (2009) Stem cell therapy in stroke. Cell Mol Life Sci 66:757-772
156. Bersano A, Ballabio E, Lanfranconi S et al (2010) Clinical studies in stem cells transplantation for stroke: a review. Curr Vasc Pharmacol 8:29-34
157. Siegel G, Schafer R, Dazzi F (2009) The immunosuppressive properties of mesenchymal stem cells. Transplantation 87:S45-S49
158. Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92-100
159. Chen J, Zhang ZG, Li Y et al (2003) Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92:692-699
160. Kinnaird T, Stabile E, Burnett MS et al (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685
161. Zacharek A, Chen J, Cui X et al (2007) Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 27:1684-1691
162. Pavlichenko N, Sokolova I, Vijde S et al (2008) Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res 1233:203-213
163. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ (2009) Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev 61:1-13
164. Yamanaka S (2007) Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39-49